BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 21703259)

  • 1. Inhibition of vascular endothelial growth factor (VEGF)-induced endothelial proliferation, arterial relaxation, vascular permeability and angiogenesis by dobesilate.
    Angulo J; Peiró C; Romacho T; Fernández A; Cuevas B; González-Corrochano R; Giménez-Gallego G; de Tejada IS; Sánchez-Ferrer CF; Cuevas P
    Eur J Pharmacol; 2011 Sep; 667(1-3):153-9. PubMed ID: 21703259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-angiogenic actions of pyrrolidine dithiocarbamate, a nuclear factor kappa B inhibitor.
    Morais C; Gobe G; Johnson DW; Healy H
    Angiogenesis; 2009; 12(4):365-79. PubMed ID: 19882112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
    Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C
    Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ARNO regulates VEGF-dependent tissue responses by stabilizing endothelial VEGFR-2 surface expression.
    Mannell HK; Pircher J; Chaudhry DI; Alig SK; Koch EG; Mettler R; Pohl U; Krötz F
    Cardiovasc Res; 2012 Jan; 93(1):111-9. PubMed ID: 22002459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-angiogenic activity of carebastine: a plausible mechanism affecting airway remodelling.
    De Luisi A; Mangialardi G; Ria R; Acuto G; Ribatti D; Vacca A
    Eur Respir J; 2009 Oct; 34(4):958-66. PubMed ID: 19357149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fisetin inhibits various attributes of angiogenesis in vitro and in vivo--implications for angioprevention.
    Bhat TA; Nambiar D; Pal A; Agarwal R; Singh RP
    Carcinogenesis; 2012 Feb; 33(2):385-93. PubMed ID: 22139440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of vascular endothelial growth factor (VEGF) as a novel approach for cancer therapy.
    Wood JM
    Medicina (B Aires); 2000; 60 Suppl 2():41-7. PubMed ID: 11188930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel compound, NP-184, inhibits the vascular endothelial growth factor induced angiogenesis.
    Lin KT; Lien JC; Chung CH; Kuo SC; Huang TF
    Eur J Pharmacol; 2010 Mar; 630(1-3):53-60. PubMed ID: 20067787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of FGF-2-induced angiogenesis by scopoletin, a coumarin compound isolated from Erycibe obtusifolia Benth, and its mechanism of action.
    Pan R; Gao X; Lu D; Xu X; Xia Y; Dai Y
    Int Immunopharmacol; 2011 Dec; 11(12):2007-16. PubMed ID: 21896339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melatonin prevents human pancreatic carcinoma cell PANC-1-induced human umbilical vein endothelial cell proliferation and migration by inhibiting vascular endothelial growth factor expression.
    Cui P; Yu M; Peng X; Dong L; Yang Z
    J Pineal Res; 2012 Mar; 52(2):236-43. PubMed ID: 21913973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HGF/NK4 inhibited VEGF-induced angiogenesis in in vitro cultured endothelial cells and in vivo rabbit model.
    Nakabayashi M; Morishita R; Nakagami H; Kuba K; Matsumoto K; Nakamura T; Tano Y; Kaneda Y
    Diabetologia; 2003 Jan; 46(1):115-23. PubMed ID: 12637990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nomilin inhibits tumor-specific angiogenesis by downregulating VEGF, NO and proinflammatory cytokine profile and also by inhibiting the activation of MMP-2 and MMP-9.
    Pratheeshkumar P; Kuttan G
    Eur J Pharmacol; 2011 Oct; 668(3):450-8. PubMed ID: 21839074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-angiogenic activity of Ipomoea obscura extract and Ipobscurine-A.
    Hamsa TP; Kuttan G
    Immunopharmacol Immunotoxicol; 2011 Sep; 33(3):488-97. PubMed ID: 21058930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiangiogenic properties of 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin: an orally bioavailable heat shock protein 90 modulator.
    Kaur G; Belotti D; Burger AM; Fisher-Nielson K; Borsotti P; Riccardi E; Thillainathan J; Hollingshead M; Sausville EA; Giavazzi R
    Clin Cancer Res; 2004 Jul; 10(14):4813-21. PubMed ID: 15269157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vernolide-A inhibits tumour specific angiogenesis by regulating proinflammatory cytokines, VEGF, MMPs and TIMP.
    Pratheeshkumar P; Kuttan G
    Eur J Pharmacol; 2011 Apr; 656(1-3):10-8. PubMed ID: 21256125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ruboxistaurin, a PKCbeta inhibitor, inhibits retinal neovascularization via suppression of phosphorylation of ERK1/2 and Akt.
    Nakamura S; Chikaraishi Y; Tsuruma K; Shimazawa M; Hara H
    Exp Eye Res; 2010 Jan; 90(1):137-45. PubMed ID: 19825373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of vascular endothelial growth factor-induced angiogenesis by scopoletin through interrupting the autophosphorylation of VEGF receptor 2 and its downstream signaling pathways.
    Pan R; Dai Y; Gao XH; Lu D; Xia YF
    Vascul Pharmacol; 2011; 54(1-2):18-28. PubMed ID: 21078410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The antiangiogenic agent neovastat (AE-941) inhibits vascular endothelial growth factor-mediated biological effects.
    Béliveau R; Gingras D; Kruger EA; Lamy S; Sirois P; Simard B; Sirois MG; Tranqui L; Baffert F; Beaulieu E; Dimitriadou V; Pépin MC; Courjal F; Ricard I; Poyet P; Falardeau P; Figg WD; Dupont E
    Clin Cancer Res; 2002 Apr; 8(4):1242-50. PubMed ID: 11948139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of angiogenesis involves in anticancer activity of riccardin D, a macrocyclic bisbibenzyl, in human lung carcinoma.
    Sun CC; Zhang YS; Xue X; Cheng YN; Liu HP; Zhao CR; Lou HX; Qu XJ
    Eur J Pharmacol; 2011 Sep; 667(1-3):136-43. PubMed ID: 21704029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dexamethasone treatment and ICAM-1 deficiency impair VEGF-induced angiogenesis in adult brain.
    Kasselman LJ; Kintner J; Sideris A; Pasnikowski E; Krellman JW; Shah S; Rudge JS; Yancopoulos GD; Wiegand SJ; Croll SD
    J Vasc Res; 2007; 44(4):283-91. PubMed ID: 17406120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.